Objectives: We investigated the lipid-lowing efficacy of short-term simvastatin and atorvastatin therapy with different dosages of routine clinical practice, and studied the association of plasma concentrations, lipid-lowing efficacy and safety of simvastatin and atorvastatin in Chinese population. Methods: 200 in-hospital patients with hypercholesterolemia were enrolled in the randomized controlled study. The patients were treated with daily doses of 20mg simvastatin, 40mg simvastatin, 10mg atorvastatin or 20mg atorvastatin orally each evening. The lipid profiles before and after 1-week treatment, as well as the plasma concentrations in the morning after 1-week treatment, which was 8 hours after last administration of simvastatin or atorvastatin, were assessed. All adverse events of simvastatin and atorvastatin were also recorded. Results: Simvastatin and atorvastatin at each dose all effectively reduced TC and LDL-c levels from baseline to week 1 (P<0.001). Simvastatin 20mg and simvastatin 40mg produced 17.5% and 24.6% reduction in LDL-c, respectively, and atorvastatin 10mg and atorvastatin 20mg produced 19.8% and 21.3% reduction in LDL-c, respectively. However, No differences were seen between different doses of simvastatin or atorvastatin. More patients at high risk in the study and in the 20mg atorvastatin group reached LDL-c target than those at very high risk (71% versus 32.8%, P<0.001 for the overall patients; 80% versus 35.7%, P<0.05 for 20mg atorvastain group). There was no significant difference in the plasma concentrations between different dosages of simvastatin and atorvastatin. The plasma concentrations in 10mg atorvastatin group were correlated with the percent reduction of LDL-c (P<0.05). No relationship was seen between the plasma concentrations and adverse events of simvastatin and atorvastatin.
Conclusions: Simvastatin and atorvastatin at different doses used by routine clinical practice can effectively reduce the TC and LDL-c levels after short-term treatment.
Only the association between plasma concentration and lipid-lowering efficacy was seen in atrovastatin 10mg group. No association was observed between the plasma concentrations, efficacy and adverse events of simvastatin and atorvastatin in other groups.
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Contributing Objectives: Obesity is one of modifiable risk factors of cardiovascular diseases. Weight regain (WR) is very common among patients who lose weight. Physiological, psychological and behavioral factors are known to cause WR. Identifying the factors associated with WR in different populations is important. This study was carried out to identify the contributing factors of WR in Ahvaz, Iran. Methods: In this case-control study, from clients referred to dietetics offices in Ahvaz, Iran from 2009 onwards, those older than 18 years and with no history of serious diseases such as cardiovascular diseases, diabetes mellitus, liver or kidney diseases and cancer were recruited. Overall 8000 files were investigated. All eligible clients who had lost at least 10 percent of initial weight and at least 6 months after their last appointments were invited to participate in this study. Weight maintainers (WM) were clients who had maintained their latest recorded weight or lower. WR was defined as regaining of at least 10 percent of the latest recorded weight. Seventy nine persons in the WR group were compared with 73 in WM group. Information about weight, age, sex, physical activities, breakfast consumption, specific changes in living conditions (e.g. divorce or death of relatives), hunger and overeating were collected from the file and by interview. Stress and depression were evaluated by DASS-21 questionnaire. Appropriate statistical tests, including Chi square and logistic regression were used for data analyses. Results: Significant contributing factors of WR were inactive life style (less than 5 minutes walking per day and lack of regular exercise), depression or stress, inappropriate strategies (overeating) in confronting usual life problems, skipping breakfast, unrestraint eating, not to eat regular meals, and excessive hunger. According to multivariate logistic regression test, the significant predicting variables of WR were irregular consumption of meals and excessive hunger. Conclusions: To prevent weight regain, diet therapy should be accompanied by behavioral, physical activity and psychological modifications.
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The Relationship Between Serum Lipids and BMI, WC, and WHR in Women in Shijiazhuang Yang Xiuchun, Liu Fan, Xiao Bing, Lu Jingchao, Li Yue, Wang Mengxiao, Jin Yaqiong Department of Cardiology, the Second Hospital of Hebei Medical University, Shijiazhuang, China
Objectives: To investigate serum lipid profiles in different age-related segments in women in Shijiazhuang and to evaluate the relationship between the serum lipids and body mass index (BMI), waist circumference (WC), and waist-hip ratio (WHR). Methods: 1992 women were recruited in this study. Body height, body mass, body mass index (BMI), waist circumference (WC), hip circumference, waist-hip ratio (WHR) and serum lipid levels were measured in the morning after an overnight fast. Results: The rate of dyslipidemia was increasing with the growing of age. The detection rates of high TC, high LDL-C, high TG and low HDL-C were 36.38%, 25.07%, 40.52% and 5.53%, respectively. There was no significant difference in lipid levels between age-related segments (P>0.05). The levels of TC, TG and LDL-C increased with the growing of BMI. The levels of TC, TG and LDL-C were significantly higher in group of obesity than in group of normal BMI (TC: 5.78AE0.96 mmol/ L vs 5.32AE0.91 mmol/L, P<0.05; TG: 1.98AE0.59 mmol/L vs 1.17AE0.38 mmol/L, P<0.05; LDL-C: 3.27AE0.44 mmol/L vs 2.86AE0.57 mmol/L, P<0.05). The level of TG was significantly higher in population with abnormal WC and WHR than in population with normal WC and WHR (P<0.05). Conclusions: The rate of dyslipidemia was associated with age in women in Shijiazhuang. The levels of TC, TG and LDL-C was positively correlated with BMI. The level of TG was positively correlated with WC and WHR.
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Evaluation of apo A I, apo B, apo A I / apo B in the diagnosis of coronary heart disease
Liu Ying The People's Hospital of Liaoning Province
Objectives: Whether the apo A I, apo B, apo I /apo B is relevant to the coronary atherosclerosis heart disease and Coronary artery lesion severity by statistical analysis, and the three level Coronary is evaluated how close to stenosis disease. Methods: In January to March 2013, a total of 512 patients underwent coronary angiography according to the results of coronary angiography were divided into A, B, JACC Vol 64/16/Suppl C j October 16-19, 2014 j GW-ICC Abstracts/Epidemiology, Prevention and Control C107
